PubMed:23592772 / 1268-1440 JSONTXT

{"project":"sentences","denotations":[{"id":"T10","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"DisGeNET5_gene_disease","denotations":[{"id":"23592772-9#51#54#gene64689","span":{"begin":51,"end":54},"obj":"gene64689"},{"id":"23592772-9#51#54#gene5970","span":{"begin":51,"end":54},"obj":"gene5970"},{"id":"23592772-9#51#54#gene6857","span":{"begin":51,"end":54},"obj":"gene6857"},{"id":"23592772-9#51#54#gene65125","span":{"begin":51,"end":54},"obj":"gene65125"},{"id":"23592772-9#9#14#diseaseC0424295","span":{"begin":9,"end":14},"obj":"diseaseC0424295"}],"relations":[{"id":"51#54#gene646899#14#diseaseC0424295","pred":"associated_with","subj":"23592772-9#51#54#gene64689","obj":"23592772-9#9#14#diseaseC0424295"},{"id":"51#54#gene59709#14#diseaseC0424295","pred":"associated_with","subj":"23592772-9#51#54#gene5970","obj":"23592772-9#9#14#diseaseC0424295"},{"id":"51#54#gene68579#14#diseaseC0424295","pred":"associated_with","subj":"23592772-9#51#54#gene6857","obj":"23592772-9#9#14#diseaseC0424295"},{"id":"51#54#gene651259#14#diseaseC0424295","pred":"associated_with","subj":"23592772-9#51#54#gene65125","obj":"23592772-9#9#14#diseaseC0424295"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"mondo_disease","denotations":[{"id":"T11","span":{"begin":41,"end":45},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005184"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"GlyCosmos15-HP","denotations":[{"id":"T10","span":{"begin":41,"end":45},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0006725"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"GlyCosmos15-MONDO","denotations":[{"id":"T11","span":{"begin":41,"end":45},"obj":"Disease"}],"attributes":[{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0005184"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"sentences","denotations":[{"id":"T10","span":{"begin":0,"end":172},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T10","span":{"begin":0,"end":172},"obj":"Sentence"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}

{"project":"HP-phenotype","denotations":[{"id":"T10","span":{"begin":41,"end":45},"obj":"Phenotype"}],"attributes":[{"id":"A10","pred":"hp_id","subj":"T10","obj":"HP:0006725"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Reducing hyper-O-GlcNAcylation decreased PDAC cell p65 activating phosphorylation (S536), nuclear translocation, NF-κB transcriptional activity, and target gene expression."}